AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Ethereum's Decline Triggers Massive Sell-Off in 180 Life Sciences Stock
ByAinvest
Friday, Aug 15, 2025 12:32 pm ET1min read
180 Life Sciences Corp. (ATNF) shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum (ETH). ETH's decline triggered a 28% decline in ATNF's stock during the regular trading session. ATNF has been on a tear lately, surging as much as 116% in a week and 755% in a month, aligning with ETH's rise in this period. The company holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation.
180 Life Sciences Corp. (ATNF) shares experienced a significant decline of 28% during the regular trading session on July 2, 2025, coinciding with a 3.38% increase in Ethereum's (ETH) price to $4,431 over a 24-hour period. The stock's after-hours trading saw a 1.45% drop, reflecting the broader market's reaction to Ethereum's price drop. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise during this period.The company holds 82,186 ETH, valued at approximately $349 million, and plans to rebrand as ETHZilla Corporation. The recent surge in ATNF's stock can be attributed to the company's Ethereum treasury strategy, which involves accumulating ETH to become a benchmark for on-chain treasury management among public companies. The strategy aims to generate cash flow for shareholders through a differentiated yield generation program facilitated by a partnership with Electric Capital.
Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands on July 2, 2025, compared to a three-month average of about 4.78 million units.
Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm, adding further credibility to the company's strategy. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/180-life-sciences-stock-plunges-ethereum-decline-2508/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet